Casey Friesenhahn
Women's Health · Austin, TXNPI 1992908859
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 252 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 252 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Mayne Pharma Commercial LLC$468
- Novo Nordisk$442
- Pfizer$329
- Exeltis, USA Inc.$302
- Astellas Pharma US Inc$258
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,629100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $1,109 |
| Mayne Pharma Commercial LLC | 15 | $468 |
| Novo Nordisk | 26 | $442 |
| Pfizer | 19 | $329 |
| Exeltis, USA Inc. | 19 | $302 |
| Astellas Pharma US Inc | 15 | $258 |
| Sumitomo Pharma America, Inc. | 10 | $184 |
| Evofem Biosciences, Inc. | 8 | $167 |
| Galderma Laboratories, L.p. | 1 | $147 |
| Millicent US Inc | 8 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $99 |
| Therapeuticsmd, Inc. | 7 | $97 |
| Agile Therapeutics, Inc. | 5 | $93 |
| Biogen | 5 | $87 |
| Coloplast | 4 | $84 |
| Dexcom, Inc. | 3 | $83 |
| Hologic Sales And Service, LLC | 4 | $82 |
| Amgen | 4 | $73 |
| Coopersurgical, Inc. | 3 | $52 |
| Scynexis, Inc. | 2 | $52 |
| Incyte Corporation | 2 | $43 |
| Avion Pharmaceuticals | 3 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Mylan Pharmaceuticals Inc. | 2 | $30 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $27 |
| Organon | 1 | $22 |
| Shield Therapeutics Inc | 1 | $21 |
| Axonics, Inc. | 1 | $20 |
| Ascend Therapeutics US, LLC | 1 | $16 |
How this compares
$4,629 in reported general payments places this provider in the 95th percentile of 609 women's health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 24 | $519 |
| Ondansetron Hcl | 12 | $332 |
Paid to pharmacies, not to this prescriber.
Other women's health in Austin
- Amanda ArmondAustin$17K
- Kelly ReaganAustin$4K
- Madison WebbAustin$4K
- Gretchen PalmerAustin$3K
- Jenna CarneyAustin$3K
- Regan McFaulAustin$3K
- Evelyn TingGrapevine$89K
- Christina TrumanWaco$70K
- Kayla CastanedaEl Paso$53K
- Shelagh LarsonFort Worth$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.